These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38216540)

  • 1. Sex-specific genetic risks for adverse outcomes after coronary revascularization procedures.
    Nurkkala JM; Aittokallio J; ; Kauko A; Niiranen T
    Interdiscip Cardiovasc Thorac Surg; 2024 Jan; 38(1):. PubMed ID: 38216540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polygenic Risk Scores for Predicting Adverse Outcomes After Coronary Revascularization.
    Aittokallio J; Kauko A; Vaura F; Salomaa V; Kiviniemi T; ; Schnabel RB; Niiranen T
    Am J Cardiol; 2022 Mar; 167():9-14. PubMed ID: 34998506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
    Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
    [No Abstract]   [Full Text] [Related]  

  • 4. Outcomes After Coronary Stenting or Bypass Surgery for Men and Women With Unprotected Left Main Disease: The EXCEL Trial.
    Serruys PW; Cavalcante R; Collet C; Kappetein AP; Sabik JF; Banning AP; Taggart DP; Sabaté M; Pomar J; Boonstra PW; Lembo NJ; Onuma Y; Simonton CA; Morice MC; McAndrew T; Dressler O; Stone GW
    JACC Cardiovasc Interv; 2018 Jul; 11(13):1234-1243. PubMed ID: 29976359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis after maternal placental events and revascularization: PAMPER study.
    Ray JG; Booth GL; Alter DA; Vermeulen MJ
    Am J Obstet Gynecol; 2016 Jan; 214(1):106.e1-106.e14. PubMed ID: 26283454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of polygenic risk scores with risks of stroke and its subtypes in Chinese.
    Yang S; Sun Z; Sun D; Yu C; Guo Y; Sun D; Pang Y; Pei P; Yang L; Millwood IY; Walters RG; Chen Y; Du H; Lu Y; Burgess S; Avery D; Clarke R; Chen J; Chen Z; Li L; Lv J;
    Stroke Vasc Neurol; 2023 Aug; ():. PubMed ID: 37640499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences after coronary artery bypass grafting with a second arterial conduit.
    Rubens FD; Wells GA; Coutinho T; Eddeen AB; Sun LY
    J Thorac Cardiovasc Surg; 2022 Feb; 163(2):686-695.e10. PubMed ID: 32493659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of Sex After Revascularization for Left Main Coronary Disease: Extended PRECOMBAT Study.
    Yang Y; Jeong YJ; Hyun J; Lee J; Kim JH; Kim S; Kang DY; Lee PH; Ahn JM; Park DW; Park SJ;
    JACC Asia; 2022 Feb; 2(1):19-29. PubMed ID: 36340254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting for Non-Protected Left Main Coronary Artery Disease: 1-Year Outcomes in a High Volume Single Center Study.
    Moț ȘDC; Șerban AM; Beyer RȘ; Cocoi M; Iuga H; Mureșan ID; Cozma S; Dădârlat-Pop A; Tomoaia R; Pop D
    Life (Basel); 2022 Feb; 12(3):. PubMed ID: 35330098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary bypass versus percutaneous intervention: sex matters. The impact of gender on long-term outcomes of coronary revascularization.
    Kurlansky P; Herbert M; Prince S; Mack M
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):554-561. PubMed ID: 28364442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
    Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
    Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex Differences in Outcomes After Percutaneous Coronary Intervention or Coronary Artery Bypass Graft for Left Main Disease: From the DELTA Registries.
    Moroni F; Beneduce A; Giustino G; Briede I; Park SJ; Daemen J; Claude Morice M; Nakamura S; Meliga E; Cerrato E; Makkar RR; D'Ascenzo F; Lucarelli C; Capranzano P; Tchetche D; Templin C; Kirtane A; Buzman P; Alfieri O; Valgimigli M; Mehran R; Colombo A; Montorfano M; Chieffo A;
    J Am Heart Assoc; 2022 Mar; 11(5):e022320. PubMed ID: 35189691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Everolimus Eluting Stents Versus Coronary Artery Bypass Graft Surgery for Patients With Diabetes Mellitus and Multivessel Disease.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
    Circ Cardiovasc Interv; 2015 Jul; 8(7):e002626. PubMed ID: 26156152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of genetic risk and outcomes in patients with atrial fibrillation: interactions with early rhythm control in the EAST-AFNET4 trial.
    Kany S; Al-Taie C; Roselli C; Pirruccello JP; Borof K; Reinbold C; Suling A; Krause L; Reissmann B; Schnabel RB; Zeller T; Zapf A; Wegscheider K; Fabritz L; Ellinor PT; Kirchhof P
    Cardiovasc Res; 2023 Aug; 119(9):1799-1810. PubMed ID: 37264683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Long-Term Outcomes Following Coronary Revascularization in Men-vs-Women with Unprotected Left Main Disease.
    Park S; Ahn JM; Park H; Kang DY; Lee PH; Kim TO; Lee J; Kim JH; Yang Y; Jeong YJ; Hyun J; Kim AR; Kim T; Oh HJ; Lee YJ; Lee JH; Jang M; Park DW; Park SJ;
    Am J Cardiol; 2021 Aug; 153():9-19. PubMed ID: 34233836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
    Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
    JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
    Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
    Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.
    Kosmidou I; Chen S; Kappetein AP; Serruys PW; Gersh BJ; Puskas JD; Kandzari DE; Taggart DP; Morice MC; Buszman PE; Bochenek A; Schampaert E; Pagé P; Sabik JF; McAndrew T; Redfors B; Ben-Yehuda O; Stone GW
    J Am Coll Cardiol; 2018 Feb; 71(7):739-748. PubMed ID: 29447735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Five-Year Outcome of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Triple-Vessel Coronary Artery Disease (from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2).
    Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Tazaki J; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
    Am J Cardiol; 2015 Jul; 116(1):59-65. PubMed ID: 25956622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.